Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

174
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Menopause01:28

Menopause

3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

459
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
459
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

396
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
396

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Testosterone Therapy Increase Risk of Atrial Fibrillation? Appraisal of the Contemporary Scientific and Clinical Evidence.

The world journal of men's health·2026
Same author

Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy vs Inadequacy.

The Journal of urology·2026
Same author

Effects of testosterone deficiency and therapy on the cardiometabolic syndrome in men.

The American journal of the medical sciences·2025
Same author

Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy.

Mayo Clinic proceedings·2024
Same author

Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review.

Sexual medicine reviews·2023
Same author

Sex steroids and COVID-19 mortality in women.

Trends in endocrinology and metabolism: TEM·2021

Related Experiment Video

Updated: Dec 29, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

701

Post-finasteride syndrome: a surmountable challenge for clinicians.

Abdulmaged M Traish1

  • 1Department of Urology, Boston University School of Medicine, Boston, Massachusetts.

Fertility and Sterility
|February 9, 2020
PubMed
Summary

Post-finasteride syndrome (PFS) involves persistent sexual, neurological, and mental side effects after finasteride use. Current evidence suggests these debilitating symptoms are real and linked to the medication.

Keywords:
Sexual dysfunctiondepressionerectile dysfunctionloss of libidosuicidal ideation

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

565
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Related Experiment Videos

Last Updated: Dec 29, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

701
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

565
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Area of Science:

  • Pharmacology
  • Neurology
  • Endocrinology

Background:

  • Post-finasteride syndrome (PFS) presents with persistent sexual, neurological, physical, and mental adverse effects after finasteride use for hair loss or prostate issues.
  • Despite increasing reports, PFS lacks recognition and effective evidence-based treatments within the medical community.
  • Existing research often suffers from incomplete adverse event assessment and data reporting.

Purpose of the Study:

  • To evaluate scientific and clinical evidence to determine if PFS is a real clinical condition caused by finasteride or incidentally associated.
  • To analyze the link between finasteride/dutasteride use and persistent adverse effects.

Main Methods:

  • Review of contemporary medical literature and clinical studies on finasteride and dutasteride.
  • Analysis of reported sexual dysfunction, depression, anxiety, and suicidal ideation associated with these drugs.

Main Results:

  • Finasteride and dutasteride use are consistently associated with sexual dysfunction that may persist in a subset of men.
  • Increased depression, anxiety, and suicidal ideation are commonly reported in men treated with these medications.
  • Evidence suggests these drugs induce persistent adverse effects in susceptible individuals.

Conclusions:

  • Finasteride and dutasteride appear to induce a constellation of persistent sexual, neurological, and physical adverse effects in a subset of men.
  • These symptoms form the basis of PFS, potentially linked to epigenetic susceptibility.
  • Further research into PFS pathophysiology is crucial for understanding and developing treatments.